Related Experiment Video
Updated: May 10, 2026

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
"Selective cell death mediated by small conditional RNAs" is not selective
1The Sydney Kimmel Comprehensive Cancer Center, Johns Hopkins Medical Institutions, Baltimore, MD USA.
Abstract:
Small conditional RNAs were used to kill cells selectively in a prior report. The method utilized the cellular innate immune response to dsRNA, causing PKR activation and cell death. We designed small conditional RNAs specific to a highly restricted transcript, that of the mesothelin gene expressed in various cancer lines and specific to a tpc/hpr fusion transcript expressed in a published "control" line. Hairpins of small conditional RNAs were functionally active in cell-free conditions. Hairpins were transfected into 6 types of cells. We observed non-specific killing of cells after transfection of the hairpins targeting the reported fusion transcript or of the mesothelin transcript. Thus when attempting to use this system for a special purpose, to target cancer mutations, the results were not satisfactory. Specifically when repeating the work described in the publication, we could not replicate the results using the methods described. Recently the publication was retracted but without comment on the validity of the reported method. Here we provide scientific basis to consider the method impaired or invalid.
Insights
Researchers found that small conditional RNAs designed to selectively kill cancer cells did not work as expected. The method, which aimed to trigger an innate immune response, resulted in non-specific cell death and could not be replicated, suggesting the technique is invalid.
Area of Science:
- Molecular Biology
- Immunology
- Oncology
Background:
- A prior report described a method using small conditional RNAs to induce selective cell death via the innate immune response (PKR activation).
- This method was proposed for targeting specific transcripts, including the mesothelin gene in cancer cells and a fusion transcript in a control line.
Purpose of the Study:
- To evaluate the efficacy and specificity of small conditional RNAs for selective cell killing.
- To replicate and validate the previously reported method targeting mesothelin and a fusion transcript.
Main Methods:
- Designed small conditional RNAs targeting mesothelin and a tpc/hpr fusion transcript.
- Tested the functionality of small conditional RNA hairpins in cell-free conditions.
- Transfected hairpins into six different cell types.
Main Results:
- Small conditional RNA hairpins were active in cell-free conditions.
- Transfection resulted in non-specific cell killing for both mesothelin and fusion transcript targets.
- The previously reported results could not be replicated.
Conclusions:
- The small conditional RNA-based cell-killing method is likely impaired or invalid due to non-specific effects.
- The inability to replicate prior findings and observed non-specific cell death undermine the method's utility for targeted cancer therapy.
More Related Videos
13:54Preparation of Cell-lines for Conditional Knockdown of Gene Expression and Measurement of the Knockdown Effects on E4orf4-Induced Cell Death
Published on: October 21, 2012
11:35Selection-dependent and Independent Generation of CRISPR/Cas9-mediated Gene Knockouts in Mammalian Cells
Published on: June 16, 2017
Related Concept Videos
Experimental RNAi
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
MicroRNAs
MicroRNAs